DEPARTMENT 13 INTERNATIONAL LTD (ASX.D13)

name changed to Delaware Thirteen Ltd

The administrator sold the company name to the same buyer. That name had no continuing or enduring value to the company. ASIC approved the change of the company's name to Delaware Thirteen Ltd effective 18 February 2020, notice of which the administrator received on 24 February 2020. The listing code D13 will remain the same.

The administrator sold the company's website, www.department13.com.au, to the same buyer, for an immaterial sum.

On 9 January 2020, ASIC granted the company relief of its financial reporting obligations for 2 years. A copy of the end of administration return was lodged by the administrators on 7 February 2020.

On 14 February, the company completed the sale of 100% of the company's shares in Department 13, Inc. and the assignment of the company's loan to D13Inc, to Department 13 Pty Ltd, in accordance with the DOCA. The buyer is now the sole shareholder of D13Inc, and D13Inc has no further liability to the company. The next phase of the DOCA will involve the company exploring opportunities for investment in and recapitalisation of the company in connection with the acquisition of a new business, subject to the required ASX Listing Rules and Corporations Act provisions.

The DOCA executed on 9 January 2020 requires the company's 100% shareholding in and loan to Department 13, Inc be respectively, sold and assigned to the proponent's nomineee by 31 January 2020 unless extended by agreement between the proponent and the administrator. The proponent has requested a two-week extension to 14 February 2020, which the deed administrator of the DOCA has granted.

The company executed a DOCA on 9 January 2020.

Creditors resolved that the company execute a DOCA substantially in accordance with the proposal of the first ranking secured creditor. Creditors' resolutions occurred today at the resumed second meeting of creditors of the company.

On 11 December 2019, the resumed second meeting of creditors convened and was held and adjourned until 19 December 2019 at 11.00am. At the further adjourned second meeting, creditors may decide the future of the company. The 3 alternatives available to creditors to vote upon are to: accept Doma's DOCA proposal; that the administration ends; or that the company is wound up.

On 3 December 2019, the administrator convened the resumed second meeting of creditors of the company to be held on 11 December 2019. The administrator intends to adjourn the meeting to ensure compliance with the Corporations Act. It is recommended that creditors resolve to accept a holding DOCA.

Department 13, Inc has appointed on an interim basis Mr. Lee Croft as Acting CEO. The company's first ranking secured creditor sourced Mr. Croft's services in the process of their due diligence and consideration of a proposal for the future of the company and/or D13Inc, through a DOCA.

The second meeting of creditors of the company was held and adjourned until 11 December 2019.

The second meeting of creditors will be held on 6 November 2019. The administrators report was sent with the notice of meeting, in which the administrators recommended that creditors resolve to accept a holding DOCA. This is to allow the administrators to explore the most advantageous sale of the company's assets including of its USA based subsidiary, Department 13, and to explore a possible recapitalisation of the company to maintain its ASX listing.

On 20 June 2019, the administrator sought and obtained orders from the Federal Court of Australia to remove the statutory pesronal liability the administrator has as a consequence of borrowing $2,000000 from Doma, primarily to continue Department 13, Inc.'s trading in the USA. The administrator also sought to extend the convening periof of the second meeting of creditors to 30 October 2019. The court application was brought to provide sufficient time to sell, recapitalise or re-finance the company and/or its wholly-owned USA-based subsidiary, Department 13, Inc.

The administrators provide clarifications to shareholder requests. In relation to the shareholder position/standing, shareholders' equity is subordinated to the claims of creditors. Shareholders will be kept apprised of the voluntary administration. Regarding options, currently there is little shareolders are able to do that would affect the outcome of the VA process. The VA process typically takes a minimum of 5 weeks (in this case, from 30 May 2019). In this case, it is expected that the process will take longer due to complexities with the company being an ASX listed company domiciled in Australia and its major asset being a wholly-owned subsidiary business based in the USA. The administrator has secured interim funding to support the USA subsidiary, Department 13, Inc., during the VA process whilst considering available options for the company and its subsidiary business.

On 3 June 2019, the administrators posted and emailed notice of the first meeting of the company's creditors to be held on 12 June 2019 at 10:30am in Sydney, NSW.

The general meeting of the company called for 3 June 2019 at 10:30am at Level 7, 333 Collins Street, Melbourne Victoria, is postponed to a date yet to be determined.

Alan Hayes of Hayes Advisory has been appointed as the Voluntary Administrator of Department 13 International Limited with immediate effect. D13 owns 100% of the shares in Department 13 Inc., a Delaware corporation.

The company issues a response to Appendix 3Z Query.

The company releases a notice of meeting. The meeting will be held on 3 June 2019 at 10:30am at Level 7, 333 Collins Street, Melbourne, Victoria. The company has also received a waiver of Listing Rule 7.3.2 from ASX which wil permit convertible notes or shares to be issued moer than 3 months after the general meting if Resolutions 2A and 2B are passed at the meeting.

The company lodges an Appendix 4C - quarterly.

The company announces a revised agreement with Domazet FT3. Under thie modified arrangement, Domazet may advance up to an additional $2 million towards the first tranche of the facility with a corresponding reduction of the second tranche of the facility. Tranche 1 may increase from $2 million to up to $4 million, and tranche 2 would potentially reduce from $3 million to $1 million. If less than $2 million is advanced as an addition to tranche 1 of the Facility the balance will remain part of tranche 2. Making advances as additions to tranche 1 if requested by D13 are solely at Domazet's discretion. The total Facility amount of $10 million and the other terms of the Facility remain the same.

The company provides a shareholder update. It details the progress it has made across a number of fronts and its strategy update.

The company lodges its Half Yearly Report and Accounts.

The Company is pleased to advise that it has secured a Line of Credit of up to $10m. The Facility will enable the Company to fund its on-going operations for the foreseeable future. This Facility will provide D13 with the necessary capital to further commercialise and leverage its existing IP, software and products. The Facility has been structured as a rolling facility, enabling D13 to draw down and repay (without penalties) at any time. In addition, interest is only payable on drawn funds and all fees are only payable at Maturity. The total Facility is in three tranches of $2m, $3m and $5m respectively. The Facility has been made available by Domazet FT3. Over the past six months the Company has been working to broaden its product offerings and revenue streams to position itself for long-term success. At the November AGM the Company detailed its strategy to shareholders which, in addition to selling MESMER. The Company has been executing on the strategy outlined at the AGM with progress being made on many fronts.

The company lodges its Appendix 4C - quarterly.

The company announces the sale of an additional MESMER system to its exclusive distributor in Latin America, Phoenix Group. The purchased system will support the rapidly growing interest in Counter-UAS technology throughout the LATAM region.

A total of 200,000,000 fully paid ordinary shares will be released from voluntary escrow on 18 December 2018 and will be tradeable from 19 December 2018, being the next trading day after lapse of the voluntary escrow period.

As the company is undergoing a pivot in strategy relating to the commercialization of its valuable network communications intellectual property, it requires a capital injection in order to sustain itself until MESMER sales are sufficiently mature or revenues from IP commercialization are received. Hence, D3 has commenced a capital raising. D13 has commenced discussions with potential investors as well as potential strategic investors. D13 has begun and will continue to look at ways to cut costs without damaging the business and has already reduced costs by over 30% on a per-month run-rate basis.

The company requests an extension of the current voluntary suspension of trading of the Company's ordinary shares. The suspension is expected to last until the earlier of normal trading on Monday 10 December 2018 or when an announcement is released to the market.

The company releases the results of its Annual General Meeting.

The company releases the Chairman and CEO's Address to Shareholders.

The company announces the receipt of a purchase order from its exclusive South Korean distributor, Korea Counter Terrorism Systems. The order for two MESMERâ„¢ systems is to be delivered in the first half of 2019 and will be used for South Korean customers to protect critical assets and facilities against the ongoing threat of commercial drones. However, due to security considerations, end customer information and details of deployment remain confidential. The per system value of the units sold are in line with previously reported revenue targets for fully configured MESMERâ„¢ systems.

The securities of Department 13 International Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of D13, pending the release of an announcement regarding funding arrangements.

The suspension of trading in the securities of Department 13 International Limited will be lifted immediately following receipt of an announcement regarding a capital raising.

The company has placed $7m of the first tranche of convertible notes. The placement resulted in the issue of 70,000,000 convertible notes, at an issue price and face value of $0.10 each.

The company issues a prospectus for an issue of up to 75,000,000 convertible notes (the Convertible Notes) at an issue price and having face value of $0.10 each.

The company announces the acquisition of the Carrier Interferometry Patent Portfolio for US$1.5m. This includes rights to 21 patents. This complements D13's already extensive IP patent protection and may be licensed to other C-UAS operators providing an additional revenue stream. It also includes continuing filing rights that will enable D13 to expand and perfect its IP protection in the C-UAS market.

The company releases an update for March 2018. Some highlights are as follows. Repeat sales from existing customers and new customer sales are expected in second half FY'18. D13 participated in the DARPA program "“ which demonstrated the strength of MESMER by taking over and safely landing a large swarm of drones. Trials with US Department of Defence and International Corporate and Government Defence entities are expected to result in further MESMER sales this calendar year. D13 expects the current suspension to end this week.

The company requests that the suspension of its securities remain in place until the company makes an announcement to the market regarding the capital raise or the commencement of trading on 26 March 2018.

The securities of Department 13 International Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement.

The securities of Department 13 International Ltd will be reinstated to official quotation immediately following the release of an announcement explaining why securities were released from escrow prior to the end of the restriction period.

The company issues a response to the ASX query relating to the release of securities from restriction on 18 December 2017.

The securities of Department 13 International Limited will be suspended from quotation immediately pursuant to ASX Listing Rule 17.3 pending an explanation of the release of securities from escrow prior to the end of the restriction period.

The securities of Department 13 International Ltd will be reinstated to official quotation immediately following the release of an announcement regarding a capital raising.

The company has received firm commitments from new and existing shareholders to subscribe for 44,350,321 million new ordinary shares at an issue price of $0.125 per share to raise A$5,543,790 million before costs. The Placement was strongly supported by institutional investors particularly out of the US and Asia and was well oversubscribed, with the initial raise of $4.5m being extended to $5.5m, to partially satisfy extra demand.

The securities of Department 13 International Ltd (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement in relation to a capital raising.

Department 13 International Limited ("Company") will be reinstated to official quotation as from 10am AEDT on Wednesday, 13 January 2016 following the Company's compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX Listing Rules. 114,403,500 ordinary shares fully paid   Security Code:     D13 

name changed from Kunene Resources Limited